Get started
Author

György Sölétormos

Observed names: G Söletormos, G Sölétormos, G. SOLETORMOS, G. Soeletormos, G. Soletormos, G. SÖLÉTORMOS, G. SöLétormos, G. Söletormos, G. Sölétormos, Györg Söletormos, György Sölétormos, György Söletormos, Soletormos, Gyorgy, Sölétormos, György
Observed institutions: University College Dublin, University of Copenhagen, Uppsala University Hospital, The University of Texas MD Anderson Cancer Center, Leiden University Medical Center, Herlev Hospital, Copenhagen University Hospital, Edinburgh Royal Infirmary, University Medical Center Utrecht, Nordsjællands Hospital, Hospital Clínic de Barcelona, St. Vincent's University Hospital, DeiC - Danish e-infrastructure Consortium, Capital Region of Denmark, University of Edinburgh
ORCID: 0000-0003-1996-9420
Observed ORCID: 0000-0003-1996-9420
OpenAlex ID: A5111809732
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
2008 · Catharine M Sturgeon, Michael J Duffy, et al. · Clinical Chemistry · 1,130
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use
2005 · M.J. DUFFY, J.M. BONFRER, et al. · International Journal of Gynecological Cancer · 317
Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer
2015 · György Sölétormos, Michael J. Duffy, et al. · International Journal of Gynecological Cancer · 255
PDF
Abnormal vital signs are strong predictors for intensive care unit admission and in-hospital mortality in adults triaged in the emergency department - a prospective cohort study
2012 · Charlotte Barfod, Marlene Lauritzen, et al. · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · 194
PDF
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Clinical Practice: Quality Requirements1
2008 · Catharine M Sturgeon, Barry R Hoffman, et al. · Clinical Chemistry · 167
Tumor markers in the management of patients with ovarian cancer
1995 · Malgorzata K. Tuxen, György Sölétormos, et al. · Cancer Treatment Reviews · 157
Validation of New Cancer Biomarkers: A Position Statement from the European Group on Tumor Markers
2015 · Michael J Duffy, Catharine M Sturgeon, et al. · Clinical Chemistry · 147
PDF
Biological Variation of Total Prostate-Specific Antigen: A Survey of Published Estimates and Consequences for Clinical Practice
2005 · G. Soletormos · Clinical Chemistry · 146
Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
2001 · M K Tuxen, G Sölétormos, et al. · British Journal of Cancer · 66
PDF
Monitoring different stages of breast cancer using tumour markers CA 15-3, CEA and TPA
2003 · G. Sölétormos, D. Nielsen, et al. · European Journal of Cancer · 62
Interpretation of results for tumor markers on the basis of analytical imprecision and biological variation
1993 · G Sölétormos, V Schiøler, et al. · Clinical Chemistry · 62
In vitro detection of circulating tumor cells compared by the CytoTrack and CellSearch methods
2015 · Thore Hillig, Peer Horn, et al. · Tumor Biology · 58
PDF
Assessment of Biological Variation and Analytical Imprecision of CA 125, CEA, and TPA in Relation to Monitoring of Ovarian Cancer
1999 · Malgorzata K. Tuxen, György Sölétormos, et al. · Gynecologic Oncology · 56
A simple clinical assessment is superior to systematic triage in prediction of mortality in the emergency department
2018 · Anne Kristine Servais Iversen, Michael Kristensen, et al. · Emergency Medicine Journal · 54
PDF
Prevalence and significance of troponin elevations in patients without acute coronary disease
2016 · Kirstine Roll Vestergaard, Camilla Bang Jespersen, et al. · International Journal of Cardiology · 48
Tumor markers cancer antigen 15.3, carcinoembryonic antigen, and tissue polypeptide antigen for monitoring metastatic breast cancer during first-line chemotherapy and follow-up
1996 · G Sölétormos, D Nielsen, et al. · Clinical Chemistry · 45
Serum tumor marker CA 125 for monitoring ovarian cancer during follow-up
2002 · M. K. Tuxen, G. SöLétormos, et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 40
The formation and design of the TRIAGE study - baseline data on 6005 consecutive patients admitted to hospital from the emergency department
2015 · Louis Lind Plesner, Anne Kristine Servais Iversen, et al. · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · 39
PDF
Calculation of limits for significant unidirectional changes in two or more serial results of a biomarker based on a computer simulation model
2014 · Flemming Lund, Per Hyltoft Petersen, et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 39
Design of Tumor Biomarker–Monitoring Trials: A Proposal by the European Group on Tumor Markers
2012 · György Sölétormos, Michael J Duffy, et al. · Clinical Chemistry · 39
PDF
Fluorescence spectroscopy and chemometrics for classification of breast cancer samples—a feasibility study using extended canonical variates analysis
2007 · Lars Nørgaard, György Sölétormos, et al. · Journal of Chemometrics · 37
Prognostic Value of Serum Tetranectin in Patients with Metastatic Breast Cancer
1993 · Claus K. Høgdall, György Sölétormos, et al. · Acta Oncologica · 36
PDF
High-sensitivity cardiac troponin T is superior to troponin I in the prediction of mortality in patients without acute coronary syndrome
2018 · Ásthildur Árnadóttir, Kirstine Roll Vestergaard, et al. · International Journal of Cardiology · 32
Routine blood tests are associated with short term mortality and can improve emergency department triage: a cohort study of >12,000 patients
2017 · Michael Kristensen, Anne Kristine Servais Iversen, et al. · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · 31
PDF
Calculation of limits for significant bidirectional changes in two or more serial results of a biomarker based on a computer simulation model
2014 · Flemming Lund, Per Hyltoft Petersen, et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 30
Works count: 113
Citation count: 3,819
H-index: 27
I10-index: 46
Year
Topic
Type